Skip to main content
Voyageur Pharmaceuticals Ltd. logo

Voyageur Pharmaceuticals Ltd. — Investor Relations & Filings

Ticker · VM ISIN · CA92918C1014 TSXV Manufacturing
Open in API
Filings indexed 501 across all filing types
Latest filing 2021-01-26 Capital/Financing Update
Country CA Canada
Listing TSXV VM

About Voyageur Pharmaceuticals Ltd.

https://voyageurpharmaceuticals.ca/

Voyageur Pharmaceuticals Ltd. develops and supplies contrast media products for medical imaging, including CT scans and fluoroscopy. The company operates using a vertically integrated "Earth to Bottle" strategy, controlling the entire supply chain from raw mineral acquisition to finished pharmaceutical product. Voyageur owns a significant, high-purity barium sulfate resource, positioning it as a secure and sustainable supplier of pharmaceutical-grade barium sulfate, the active ingredient in its commercialized contrast agents (e.g., SmoothX® and SmoothHD® series). This vertical control aims to ensure supply security and cost competitiveness, primarily targeting the North American market. The company is also actively developing iodine-based contrast media and V-Gas® Effervescent Granules to expand its portfolio of diagnostic imaging solutions.

Recent filings

Filing Released Lang Actions
Material change report - English.pdf
Capital/Financing Update Classification · 95% confidence The document is titled 'FORM 51-102F3 Material Change Report' and details a material change involving a private placement financing and a director's retirement. It includes specifics about the private placement, proceeds usage, related party participation, and regulatory approvals. The form number 51-102F3 is a Canadian regulatory filing used to disclose material changes. The content focuses on financing activity and a director retirement announcement but is primarily about the private placement financing. The document is not a full annual or interim report, nor is it a simple announcement of a report publication. It is a regulatory filing disclosing material changes, including financing and management changes. Given the detailed disclosure of financing and director retirement, but the primary focus on the private placement financing, the best fitting category is Capital/Financing Update (CAP). The document is over 6000 characters and contains substantive details about the financing, not just a brief announcement. Therefore, the classification is CAP with high confidence.
2021-01-26 English
Report of exempt distribution excluding schedule 1 of Form 5.pdf
Regulatory Filings Classification · 95% confidence The document is titled 'Form 45-106F1 Report of Exempt Distribution' and contains detailed information about securities distribution, including issuer information, underwriter information, distribution dates, purchaser details, types of securities distributed, and jurisdictional breakdowns of purchasers and exemptions relied upon. This form is a regulatory filing used to report exempt distributions of securities, typically filed with securities regulators such as the British Columbia Securities Commission (BCSC). It is not a financial report like an annual or interim report, nor is it an earnings release or management discussion. It is a specific regulatory filing reporting exempt securities distributions. Therefore, the document fits best under the category of Regulatory Filings (RNS). The document length (15,000 characters) and detailed content confirm it is a full filing, not just an announcement or certification.
2021-01-26 English
Report of exempt distribution excluding schedule 1 of Form 5 (amended).pdf
Regulatory Filings Classification · 100% confidence The document is titled 'Form 45-106F1 Report of Exempt Distribution' which is a regulatory filing form used in Canadian securities regulation to report exempt distributions of securities. The content includes detailed issuer information, certification, and underwriter details, consistent with a regulatory compliance report rather than a financial report or announcement. There is no indication of financial statements, earnings data, or management discussion. The document is a regulatory filing form, not an annual report, earnings release, or other financial report. Therefore, the appropriate classification is Regulatory Filings (RNS).
2021-01-19 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing the completion of the second and final closing of a private placement financing by Voyageur Pharmaceuticals Ltd. It details the number of units issued, the proceeds raised, use of proceeds, related party participation, and a director's retirement. There are no financial statements or detailed financial analysis present. The document focuses on capital raising activities and a management change announcement but primarily centers on the private placement financing. It is not an annual or interim report, audit report, earnings release, or any other detailed financial report. The primary purpose is to update on financing and related corporate matters. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2021-01-18 English
Report of exempt distribution excluding schedule 1 of Form 5.pdf
Regulatory Filings
2021-01-12 English
Material change report - English.pdf
Capital/Financing Update Classification · 95% confidence The document is titled 'FORM 51-102F3 Material Change Report' and details a material change related to a private placement financing by Voyageur Minerals Ltd. It includes specifics about the offering, proceeds, use of funds, and regulatory approvals. The form number 51-102F3 is a Canadian regulatory filing used to disclose material changes, typically related to financing or corporate events. The content focuses on a financing update rather than a full financial report or earnings release. It is not an annual or interim report, nor a call transcript or management discussion. The document is a regulatory announcement about a capital raising event, fitting the Capital/Financing Update category (CAP). The document length (5699 characters) and detailed description of the financing support this classification with high confidence.
2021-01-12 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.